PSEN1 and Alzheimer disease: In the same mouse model of AD, Aβ-specific Th1 cells were intracerebroventricularly injected into the Cerebrial spinal fluid of APP/PS1 mice, and showed to target Aβ plaques that resulted in reduction of Aβ plaque load and slight enhancement of neurogenesis [54].